Finding the solution for incomplete small bowel capsule endoscopy by Cotter, José de Almeida Berkeley et al.
World Journal of 
Gastrointestinal Endoscopy
World J Gastrointest Endosc  2013 December 16; 5(12): 584-609
ISSN 1948-5190 (online)
www.wjgnet.com
584	 Narrow	band	imaging	with	magnification	for	the	diagnosis	of	lesions	in	the	
upper	gastrointestinal	tract
Singh R, Hussain A, Loong CK
590	 Endoscopic	mucosal	resection	of	Barrett’s	esophagus	detects	high	prevalence	
of	subsquamous	intestinal	metaplasia	
Yachimski P, Shi C, Slaughter JC, Washington MK
595	 Finding	the	solution	for	incomplete	small	bowel	capsule	endoscopy
Cotter J, Dias de Castro F, Magalhães J, Moreira MJ, Rosa B
600	 Repeat	endoscopic	submucosal	dissection	for	recurrent	gastric	cancers	after	
endoscopic	submucosal	dissection
Shimamura Y, Ishii N, Nakano K, Ikeya T, Nakamura K, Takagi K, Fukuda K, Suzuki K, 
Fujita Y
605	 A	case	of	neuroendocrine	tumor	G1	with	unique	histopathological	growth	
progress	
Hirai M, Matsumoto K, Ueyama H, Fukushima H, Murakami T, Sasaki H, Nagahara A, 
Yao T, Watanabe S
Contents
MINIREVIEWS
Monthly  Volume 5  Number 12  December 16, 2013
December 16, 2013|Volume 5|Issue 12|WJGE|www.wjgnet.com I
CASE REPORT
BRIEF ARTICLE
Contents
World Journal of Gastrointestinal Endoscopy
Volume 5  Number 12  December 16, 2013
APPENDIX
EDITORS FOR 
THIS ISSUE
Responsible Assistant Editor: Xin-Xin Che                 Responsible Science Editor: Xiu-Xia Song
Responsible Electronic Editor: Dan-Ni Zhang                 
Proofing Editor-in-Chief: Lian-Sheng Ma
NAME	OF	JOURNAL	
World Journal of  Gastrointestinal Endoscopy
ISSN
ISSN 1948-5190 (online)
LAUNCH	DATE
October 15, 2009
FREQUENCY
Monthly
EDITORS-IN-CHIEF
Nadeem Ahmad Afzal, MD, MBBS, MRCP, 
MRCPCH, Consultant Paediatric Gastroenter-
ologist and Honorary Senior Clinical Lecturer, Room 
EG244D, Mailpoint 44, Floor G, Southampton General 
Hospital, Tremona Road, Southampton, Hampshire 
SO16 6YD, United Kingdom
Spiros D Ladas, MD, Professor of  Medicine 
and Gastroenterology, Medical School, University 
of  Athens, Chairman, 1st Department of  Internal 
Medicine-Propaedeutic, Director, Medical Section, 
“Laiko” General Hospital of  Athens, 17 Agiou 
Thoma Street, 11527 Athens, Greece
Juan Manuel-Herrerías, MD, PhD, AGAF, Profe-
ssor, Gastroenterology Service, Hospital Universitario 
Virgen Macarena, Aparato Digestivo, Avda. Dr. 
Fedriani, s/n, 41071 Sevilla, Spain
Till Wehrmann, MD, PhD, Professor, FB Gastro-
enterologie Gastro-enterologie, Deutsche Klinik fuer 
Diagnostik, Aukammallee 33, 65191 Wiesbaden, 
Germany
EDITORIAL	OFFICE
Jin-Lei Wang, Director
Xiu-Xia Song, Vice Director
World Journal of  Gastrointestinal Endoscopy
Room 903, Building D, Ocean International Center,
No. 62 Dongsihuan Zhonglu, Chaoyang District, 
Beijing 100025, China
E-mail: bpgoffice@wjgnet.com
http://www.wjgnet.com
Telephone: +86-10-85381891
Fax: +86-10-85381893
PUBLISHER
Baishideng Publishing Group Co., Limited
Flat C, 23/F., Lucky Plaza, 
315-321 Lockhart Road, 
Wan Chai, Hong Kong, China
Fax: +852-65557188
Telephone: +852-31779906
E-mail: bpgoffice@wjgnet.com
http://www.wjgnet.com
PUBLICATION	DATE
December 16, 2013
COPYRIGHT
© 2013 Baishideng Publishing Group Co., Limited. Articles 
published by this Open-Access journal are distributed 
under the terms of  the Creative Commons Attribution 
Non-commercial License, which permits use, distribution, 
and reproduction in any medium, provided the original 
work is properly cited, the use is non commercial and is 
otherwise in compliance with the license.
SPECIAL	STATEMENT	
All articles published in this journal represent the view-
points of  the authors except where indicated otherwise.
INSTRUCTIONS	TO	AUTHORS
Full instructions are available online at http://www.wjgnet.
com/1948-5190/g_info_20100316080002.htm 
ONLINE	SUBMISSION	
http://www.wjgnet.com/esps/
ABOUT COVER
December 16, 2013|Volume 5|Issue 12|WJGE|www.wjgnet.com II
I-V  Instructions	to	authors
Editorial	Board	Member	of	World	Journal	of	Gastrointestinal	Endoscopy,	
Tony	Chiew	Keong	Tham,	MD,	Consultant	Gastroenterologist,	Ulster	Hospital,	
Dundonald,	Belfast	BT16	1RH,	Northern	Ireland,	United	Kingdom
World Journal of  Gastrointestinal Endoscopy (World J Gastrointest Endosc, WJGE, online ISSN 
1948-5190, DOI: 10.4253) is a peer-reviewed open access (OA) academic journal that 
aims to guide clinical practice and improve diagnostic and therapeutic skills of  clinicians.
    WJGE covers topics concerning gastroscopy, intestinal endoscopy, colonoscopy, 
capsule endoscopy, laparoscopy, interventional diagnosis and therapy, as well as advances 
in technology. Emphasis is placed on the clinical practice of  treating gastrointestinal 
diseases with or under endoscopy. 
    We encourage authors to submit their manuscripts to WJGE. We will give priority 
to manuscripts that are supported by major national and international foundations and 
those that are of  great clinical significance.
World Journal of  Gastrointestinal Endoscopy is now indexed in PubMed Central, PubMed, 
Digital Object Identifier, and Directory of  Open Access Journals. 
I-IV	 	Editorial	Board
AIM AND SCOPE
INDEXING/ABSTRACTING 
FLYLEAF
 BRIEF ARTICLE
Finding the solution for incomplete small bowel capsule 
endoscopy
José Cotter, Francisca Dias de Castro, Joana Magalhães, Maria João Moreira, Bruno Rosa
José Cotter, Francisca Dias de Castro, Joana Magalhães, 
Maria João Moreira, Bruno Rosa, Gastroenterology Depart-
ment, Centro Hospitalar do Alto Ave, 4835-044 Guimarães, 
Portugal
José Cotter, Life and Health Sciences Research Institute (ICVS), 
School of Health Sciences, University of Minho, 4710-057 Bra-
ga/Guimarães, Portugal
José Cotter, ICVS/3B’s, PT Government Associate Laboratory, 
4710-057 Braga/Guimarães, Portugal
Author contributions: Cotter J developed and coordinated 
the study, drafted and critically revised the manuscript and ap-
proved the final version to be submitted; Dias de Castro F re-
viewed the capsule endoscopy videos, performed data analysis 
and literature research and drafted the manuscript; Magalhães 
J participated in the design of the study and statistical analysis; 
Moreira MJ and Rosa B revised the manuscript and reviewed 
the capsule endoscopy videos; all the authors read and approved 
the final manuscript.
Correspondence to: José Cotter, MD, Gastroenterology De-
partment, Centro Hospitalar do Alto Ave, Rua dos Cutileiros, 
4835-044 Guimarães, Portugal. jcotter@chaa.min-saude.pt
Telephone: +351-253-540330   Fax: +351-253-421308
Received: September 14, 2013  Revised: November 1, 2013
Accepted: November 15, 2013
Published online: December 16, 2013 
Abstract
AIM: To evaluate whether the use of real time viewer 
(RTV) and administration of domperidone to patients 
with delayed gastric passage of the capsule could 
reduce the rate of incomplete examinations (IE) and 
improve the diagnostic yield of small bowel capsule 
endoscopy (SBCE). 
METHODS: Prospective single center interventional 
study, from June 2012 to February 2013. Capsule lo-
cation was systematically checked one hour after in-
gestion using RTV. If it remained in the stomach, the 
patient received 10 mg domperidone per os and the 
location of the capsule was rechecked after 30 min. If 
the capsule remained in the stomach a second dose of 
10 mg of domperidone was administered orally. After 
another 30 min the position was rechecked and if the 
capsule remained in the stomach, it was passed into 
the duodenum by upper gastrointestinal (GI) endos-
copy. The rate of IE and diagnostic yield of SBCE were 
compared with those of examinations performed be-
fore the use of RTV or domperidone in our Department 
(control group, January 2009 - May 2012).
RESULTS: Both groups were similar regarding age, 
sex, indication, inpatient status and surgical history. 
The control group included 307 patients, with 48 
(15.6%) IE. The RTV group included 82 patients, with 
3 (3.7%) IE, P  =  0.003. In the control group, average 
gastric time was significantly longer in patients with 
IE than in patients with complete examination of the 
small bowel (77 min vs  26 min, P  =  0.003). In the RTV 
group, the capsule remained in the stomach one hour 
after ingestion in 14/82 patients (17.0%) vs  48/307 
(15.6%) in the control group, P  =  0.736. Domperidone 
did not significantly affect small bowel transit time (260 
min vs  297 min, P  =  0.229). The capsule detected pos-
itive findings in 39% of patients in the control group 
and 49% in the RTV group (P  =  0.081). 
CONCLUSION: The use of RTV and selective adminis-
tration of domperidone to patients with delayed gastric 
passage of the capsule significantly reduces incomplete 
examinations, with no effect on small bowel transit 
time or diagnostic yield.
© 2013 Baishideng Publishing Group Co., Limited. All rights 
reserved.
Key words: Small bowel capsule endoscopy; Prokinetic 
drugs; Domperidone; Incomplete examination 
Core tip: Incomplete small bowel capsule endoscopy 
(SBCE) is an important limitation of the technique and 
may occur in up to 20% of patients. Delayed gastric 
passage of the capsule is a major factor leading to 
incomplete SBCE. Selective administration of oral dom-
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peridone to patients with delayed gastric passage of 
the capsule assessed with the real time viewer (RTV) 
effectively reduces the rate of incomplete SBCE. The 
administration of domperidone does not influence small 
bowel transit time of the capsule. There is an overall 
trend towards higher diagnostic yield of SBCE when 
domperidone is selectively administered. The use of the 
RTV should be adopted systematically in patients un-
dergoing small bowel capsule endoscopy.
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INTRODUCTION
Small bowel capsule endoscopy (SBCE) was introduced 
in clinical practice in 2001, and it proved to be a valuable 
non-invasive technique to examine the small-bowel[1]. 
SBCE may be useful in a wide range of  clinical set-
tings, such as obscure gastrointestinal (GI) bleeding[2], 
suspected and known Crohn’s disease (CD)[3-5], celiac 
disease[6] and polyposis syndromes[7], with a higher diag-
nostic yield when compared to conventional diagnostic 
techniques[2,4,8-11]. An important limitation of  SBCE is 
the possibility of  incomplete examination of  the small-
bowel, which occurs when the capsule does not reach 
the cecum within the recording time of  approximately 9 
h. The rate of  IE is approximately 20% to 30% in most 
studies[12,13]. In such cases, the value of  SBCE is limited 
by the fact that it may miss lesions located in the distal 
segments of  the small bowel, eventually leading to the 
need for further examinations and increased costs[14]. 
Retrospective studies identified some factors that may 
be associated with incomplete small-bowel SBCE exami-
nation, such as inpatient status[14], previous abdominal 
surgery[14] and prolonged gastric transit time (GTT)[14,15], 
while the effect of  age or medical conditions such as di-
abetes mellitus remains controversial[16]. Currently, there 
is no consensus regarding the use of  prokinetic drugs in 
SBCE to reduce the rate of  IE with SBCE[17]. In theory, 
prokinetics might be useful by improving gastric empty-
ing, but their routine use in patients submitted to SBCE 
is not widely established[17]. Randomized prospective 
studies failed to demonstrate an improvement in SBCE 
completion rates with the use of  metoclopramide, ad-
ministered before the procedure[18,19]. One of  the recent 
advances in the field of  SBCE is the availability of  a 
portable external viewer for direct monitoring of  the 
images received during the procedure. The new Given® 
Data Recorder (DR3) with the real time viewer (RTV) 
enables real-time viewing during SBCE procedure (Figure 
1). The European Society of  Gastrointestinal Endos-
copy (ESGE) recommended that patients at increased 
risk for IE might benefit from the use of  the RTV peri-
procedurally, with subsequent endoscopic placement of  
the capsule in the duodenum when indicated[20]. The aim 
of  our study was to assess whether the prokinetic agent 
domperidone, in association with the RTV, could re-
duce the rate of  IE and improve the diagnostic yield of  
SBCE.
MATERIALS AND METHODS
We conducted a single center prospective interventional 
study, comparing the use of  domperidone in association 
with RTV in consecutive patients undergoing SBCE 
from June 2012 to February 2013 (RTV group) vs a con-
trol group of  patients who had been submitted to SBCE 
following the standard procedure with no use of  RTV 
or domperidone, from January 2009 to May 2012, in our 
Department. The RTV images were viewed by gastro-
enterologists with a large experience in SBCE to check 
the capsule position during the procedure. The RTV was 
used to confirm the passage of  the capsule to the small-
bowel one hour after ingestion. If  the capsule remained 
in the stomach, 10 mg of  domperidone were adminis-
tered per os and the location of  the capsule was rechecked 
after 30 min. if  it still remained in the stomach, an addi-
tional dose of  10 mg of  domperidone was administered 
orally and after another 30 min the location of  the capsule 
was rechecked; then if  still in the stomach the capsule was 
placed directly in the duodenum by upper endoscopy us-
ing a basket. All patients followed a 24 h clear liquid diet 
and 12 h fasting prior to SBCE (PillCam® SB2, Given® 
Imaging Ltd. Yoqneam, Israel), and were advised not to 
eat for 4 h after swallowing the capsule. No oral purge 
was administered. Patients with obstructive symptoms, 
known small bowel strictures and/or in whom some 
bowel purge or prokinetics were used did not enter the 
study. One experienced gastroenterologist, with more 
than 100 SBCE procedures, reviewed SBCE images us-
ing RAPID Reader® (Given® Diagnostic Imaging Sys-
tem, Given® Imaging). The completion rate was defined 
as the frequency of  SBCE reaching the cecum within 
the battery life (approximately 9 h). Gastric transit time 
(GTT) was recorded from the first gastric image to the 
first duodenum image, and small-bowel transit time 
(SBTT) was recorded from the first duodenum image 
to the first cecal image, or alternatively the last image of  
the small bowel if  the capsule did not reach the cecum 
within recording time. 
Statistical analysis
Continuous variables were expressed as mean ± SD and 
analyzed with the unpaired t-test. Fisher’s exact test was 
used to compare incomplete examinations rate and di-
agnostic yield between the two groups. A P-value of  less 
than 0.05 was considered statistically significant. Statisti-
cal analysis was performed using SPSS® (version 17.0 for 
Windows®, SPSS inc®, Chicago, IL, USA). All patients 
gave their informed consent prior to their inclusion in 
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RESULTS
A total of  84 consecutive SBCE were performed after 
the introduction of  RTV in our Department. Two pro-
cedures were excluded because the capsule was ad initium 
passed into the duodenum under endoscopic assistance 
using the AdvanCE® delivery system. In the control 
group, a total of  359 SBCE were retrospectively re-
viewed. Forty procedures were excluded because patients 
had received bowel preparation with polyethylene glycol 
prior to SBCE in the setting of  a clinical trial[21], and 
another 12 patients were excluded because the capsule 
was immediately passed into the duodenum under en-
doscopic assistance using the AdvanCE® system, due to 
swallowing disorders or previous gastric surgery. Thus, 
a total of  82 patients using the RTV and 307 matched 
controls were included in the study analysis. The baseline 
clinical characteristics and indications for SBCE in both 
groups are summarized in Table 1. Variables such as 
age, gender, previous abdominal surgery, inpatient status 
and indication for SBCE were not significantly different 
between the two groups. The rate of  IE was 15.6% (n 
= 48) in the control group vs 3.7% (n = 3) in the RTV 
group (P = 0.003). In the RTV group, domperidone 
was administered in 14/82 patients (17.0%), in whom 
the capsule remained in the stomach 1 h after ingestion, 
while in the control group the proportion of  patients 
with the capsule remaining in the stomach 1 h after in-
gestion was 48/307 (15.6%), P = 0.736. In the control 
group, average gastric time was significantly longer in 
patients with IE than in patients with complete examina-
tion of  the small bowel (77 min vs 26 min, P = 0.003). 
In the RTV group, no differences were observed in the 
SBTT among patients who received or did not receive 
domperidone (260 min vs 297 min, P = 0.229). In one 
patient (7.0%) out of  the 14 patients in the RTV group 
in whom domperidone was administered, the capsule re-
mained in the stomach two hours after ingestion, and an 
upper endoscopy was performed to deliver the capsule 
to the duodenum using a basket. SBCE positive find-
ings were observed in 39% of  the control group vs 49% 
of  the RTV group (P = 0.081). None of  the 14 patients 
who received domperidone had any side effect related to 
the drug.
DISCUSSION
SBCE emerged as a valuable non-invasive diagnostic 
technique to investigate the entire small-bowel. However, 
a major drawback is the rate of  incomplete examina-
tions, reaching up to 20% to 30%[12,13]. Some conditions 
have been associated with incomplete small bowel exam-
ination, such as inpatient status[14] or previous abdominal 
surgery[14], while the effect of  age or medical conditions 
such as diabetes mellitus remain controversial[16]. Im-
portantly, delayed GTT has been consistently reported 
as a leading cause of  incomplete small bowel examina-
tion[14,15]. Our study supports the hypothesis that the 
systematic use of  the RTV included in the new Given® 
Data Recorder (DR3), in association with domperidone 
to overcome delayed gastric transit in selected cases, en-
hancesthe completion rate of  SBCE. Domperidone is a 
type Ⅱ dopamine antagonist similar to metoclopramide, 
with similar effects on gastric emptying but with lower 
central side effects[22]. Domperidone is not approved by 
the FDA for use in the United States but is widely used 
in Europe. To our knowledge, none of  the published 
studies in this area used domperidone as a prokinetic to 
improve cecal intubation rates. A recent randomized con-
trolled trial which used intramuscular metoclopramide 
15 min before capsule ingestion, reported a decrease in 
GTT with no change in SBTT or complete examina-
tion rate[23], reinforcing that it may also be influenced by 
other variables. In our study, domperidone significantly 
contributed to reduce the rate of  IE. The drug was only 
administered in patients with delayed gastric passage 
of  the capsule, documented with the RTV. Moreover, 
there was no significant difference in SBTT among 
patients who received or did not receive domperidone. 
The fact that the SBTT was similar in patients receiving 
or not domperidone (260 min vs 297 min, respectively, 
P = NS) is relevant, because it supports the hypothesis 
that delayed gastric emptying may be a more determi-
nant factor leading to incomplete SBCE than delayed 
transit of  the capsule in the small bowel; the fact that 
the transit time of  the capsule in the small bowel is not 
significantly reduced by the prokinetic is also important, 
because a faster passage of  the capsule through the small 
bowel has been associated with lower diagnostic yield 
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Figure 1  Real time viewer detecting the capsule inside the stomach more 
than one hour after ingestion.
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of  SBCE[24]. Indeed, Westerhof  et al[24] found a positive 
correlation between the diagnostic yield of  SBCE and 
longer small bowel transit time, irrespective of  whether 
the capsule reached the cecum within recording time. In 
our series, despite the reduction of  IE, we did not find 
a significantly higher diagnostic yield in the RTV group 
(49% vs 39% in the control group). Recently, Gao et al[20] 
showed that delivering the capsule to the duodenum by 
upper endoscopy using a basket in patients with delayed 
gastric transit, identified with RTV, improved the rate of  
complete small-bowel examinations, resulting in higher 
diagnostic yield of  SBCE. We could speculate whether it 
would be useful to routinely place the capsule in the du-
odenum with the AdvanCE® from the beginning of  the 
examination. However, this strategy would be both inva-
sive and add costs to a procedure that is already expen-
sive. Moreover, it is not possible to accurately predict to 
which patients it would be helpful, making it unsuitable 
to implement as a routine procedure in clinical practice. 
In our study, only one patient in the RTV group required 
endoscopic-assisted placement of  the capsule into the 
duodenum. Our results support that to overcome de-
layed gastric transit time identified by the RTV, non-
invasive procedures such as selective administration of  
oral domperidone to patients with delayed gastric pas-
sage of  the capsule documented with the RTV, should 
be the method of  choice. This strategy has the merit of  
strictly selecting the patients to undergo pharmacological 
and/or flexible endoscopic intervention. Further studies 
are needed to support the association between complete 
examination and higher diagnostic yield of  SBCE[25]. 
Although this was not a prospective randomized clinical 
trial, both groups were homogeneous regarding the most 
common conditions associated with incomplete SBCE. 
In conclusion, our results support that the use of  RTV 
to monitor the position of  the capsule during SBCE and 
administration of  domperidone in the case of  delayed 
gastric passage, significantly enhances the completion 
rate of  SBCE. Whether such strategy could contribute 
to improve the diagnostic yield of  SBCE will require 
further investigation. 
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